Evaluation of the biological behavior of decellularized pulmonary homografts: An experimental sheep model;Avaliação do comportamento biológico de homoenxertos valvares pulmonares descelularizados: Estudo experimental em ovinos

Brazilian Journal of Cardiovascular Surgery

Volumn 25, Issue 3, 2010, Pages 377-387

  Navarro, Fábio Binhara ^a   da Costa, Francisco Diniz Affonso ^b   Mulinari, Leonardo Andrade ^c   Pimentel, Gustavo Klug ^a   Roderjan, João Gabriel ^b   Vieira, Eduardo Discher ^b   de Noronha, Lúcia ^b   Miyague, Nelson Itiro ^b  

^a Hospital Pequeno Príncipe of Curitiba

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Heart Valve Diseases; Homologous; Host vs Graft Reaction; Transplantation

Indexed keywords

EID: 78649959534     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/s0102-76382010000300015     Document Type: Article

References (36)

1. O'Brien MF, Stafford G, Gardner M, Pohlner P, McGiffin D, Johnston N, et al. The viable cryopreserved allograft aortic valve. J Card Surg. 1987;2(1Suppl):153-67.
2. Penta A, Qureshi S, Radley-Smith R, Yacoub MH. Patient status 10 or more years after 'fresh' homograft replacement of the aortic valve. Circulation. 1984;70(3 Pt 2):I182-6.
3. Costa FDA, Dohmen P, Lopes SV, Pohl F, Vilani R, Vieira E, et al. Estudo experimental com heteroenxertos valvares descelularizados: a prótese do futuro. Rev Bras Cir Cardiovasc. 2004;19(1):74-82.
4. Mitchell RN, Jonas RA, Schoen FJ. Structure-function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg. 1995;60(2 Suppl):S108-12.
5. Homann M, Haehnel JC, Mendler N, Paek SU, Holper K, Meisner H, et al. Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur J Cardiothorac Surg. 2000;17(6):624-30.
6. Neves JP, Gulbenkian S, Ramos T, Martins AP, Caldas MC, Mascarenhas R, et al. Mechanisms underlying degenaration of cryopreserverd vascular homografts. J Thorac Cardiovasc Surg. 1997;113(6):1014-21.
7. Oei FB, Stegmann AP, van der Ham F, Zondervan PE, Vaessen LM, Baan CC, et al. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts. J Heart Valve Dis. 2002;11(3):315-24.
8. Baskett RJ, Ross DB, Nanton MA, Murphy DA. Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immungenicity? J Thorac Cardiovasc Surg. 1996;112(5):1170-8.
9. Christenson JT, Vala D, Sierra J, Beghetti M, Kalangos A. Blood group incompatibility and accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg. 2004;127(1):242-50.
10. Hawkins JA, Hillman ND, Lambert LM, Jones J, Di Russo GB, Profaizer T, et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg. 2003;126(1):247-52.
11. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg. 1995;60(2 Suppl):S127-30.
12. Shaddy RE, Hunter DD, Osborn KA, Lambert LM, Minich LL, Hawkins JA. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation. 1996;94(5):1063-7.
13. Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC, et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg. 2000;119(2):324-30.
14. Breinholt JP 3rd, Hawkins JA, Lambert LM, Fuller TC, Profaizer T, Shaddy RE. A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery. Circulation. 2000;102(19 Suppl 3):III179-82.
15. Pompilio G, Polvani G, Piccolo G, Guarino A, Nocco A, Innocente A, et al. Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: implications with valve dysfunction. Ann Thorac Surg. 2004;78(2):557-63.
16. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, et al. Tissue engineering of heart valves: human endothelial cell seeding on detergent acellularized porcine valves. Eur J Cardiothorac Surg. 1998;14(3):279-84.
17. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehydefixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg. 1999;11(4 Suppl 1):194-200.
18. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis. 2002;11(4):457-62.
19. Kim WG, Park JK, Lee WY. Tissue-engineered heart valve leaflets: an effective method of obtaining acellularized valve xenografts. Int J Artif Organs. 2002;25(8):791-7.
20. Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner E, Wiegel G, et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs. 2003;26(5):421-7.
21. Dohmen PM, Ozaki S, Yperman J, Flameng W, Konertz W. Lack of calcification of tissue engineered heart valves in juvenile sheep. Semin Thorac Cardiovasc Surg. 2001;13(4 Suppl 1):93-8.
22. Dohmen PM, Ozaki S, Verbeken E, Yperman J, Flameng W, Konertz WF. Tissue engineering of an auto-xenograft pulmonary heart valve. Asian Cardiovasc Thorac Surg. 2002;10(1):25-30.
23. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg. 2001;71(5 Suppl):S428-32.
24. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation. 2000;102(19 Suppl 3):III-50-5.
25. Elkins RC, Lane MM, Capps SB, McCue C, Dawson PE. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg. 2001;13(4 Suppl 1):82-6.
26. Elkins RC, Goldstein S, Hewitt CW, Walsh SP, Dawson PE, Ollerenshaw JD, et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg. 2001;13(4 suppl 1):87-92.
27. Dohmen PM, Ozaki S, Nitsch R, Yperman J, Flameng W, Konertz W. A tissue engineered heart valve implanted in juvenile sheep model. Med Sci Monit. 2003;9(4):BR97-BR104.
28. O'Brien MF, Harrocks S, Stafford EG, Gardner MA, Pohlner PG, Tesar PJ, et al. The homograft aortic valve: a 29-year, 99.3% follow-up of 1,022 valve replacements. J Heart Valve Dis. 2001;10(3):334-44.
29. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003;23(6):1002-6.
30. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg. 2002;74(5):1438-42.
31. Meuris B, Ozaki S, Herijgers P, Verbeken E, Flameng W. Influence os species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue. Semin Thorac Cardiovasc Surg. 2001;13(4 Suppl 1):99-105.
32. Ozaki S, Dohmen PM, Flameng W, Konertz W. Superiority of tissue-engineered heart valves to stentless porcine aortic bioprostheses. Artif Organs. 2001;25:846-9.
33. Hopkins RA, Jones LA, Wolnbarger L, Moore MA, Bert AA, Lo?and GK. Decellularization reduces calci?cation while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep. J Thorac Cardiovasc Surg. 2009;137(4):907-13.
34. Numata S, Fujisato T, Niwaya K, Ishibashi-Ueda H, Nakatani T, Kitamura S. Immunological and histological evaluation of decellularized allograft in a pig model: comparyson with cryopreserved allograft. J Heart Valve Dis. 2004;13(6):984-90.
35. Lopes SA, Costa FD, Paula JB, Dhomen P, Phol F, Vilani R, et al. Decellularized heterografts versus cryopreserved homografts: experimental study in sheep model. Rev Bras Cir Cardiovasc. 2009;24(1):15-22.
36. Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation. 2006;114(1 Suppl):I132-7.